Cytoreduction with hyperthermic intra peritoneal and intra thoracic chemotherapy for metastatic Sertoli-Leydig cell tumor of the ovary

Nicholas K. Larsen, Matthew J. Reilly, Seunghyug Kwon, Brian W. Loggie, Marcus W. Balters

Research output: Contribution to journalArticlepeer-review

Abstract

Sertoli Leydig cell tumor (SLCT) is a rare sex-cord stromal tumor of the ovary that generally has a benign course. Here, we report an unusual case of recurrent, metastatic SLCT and its unique management with a combination of cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, hyperthermic intrathoracic chemotherapy, and systemic chemotherapy.

Original languageEnglish (US)
Article number100638
JournalGynecologic Oncology Reports
Volume34
DOIs
StatePublished - Nov 2020

All Science Journal Classification (ASJC) codes

  • Oncology
  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'Cytoreduction with hyperthermic intra peritoneal and intra thoracic chemotherapy for metastatic Sertoli-Leydig cell tumor of the ovary'. Together they form a unique fingerprint.

Cite this